Improving stroke prevention for patients with atrial fibrillation in emergency departments
Optimizing Stroke Prophylaxis of Acute Atrial Fibrillation with an Electronic Clinical Decision Support Tool: A Stepped-Wedge Cluster Randomized Trial Design
This study is looking at how to help doctors in emergency rooms prescribe blood thinners better for patients with atrial fibrillation, which can help lower the risk of stroke.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-11145021 on NIH RePORTER |
What this research studies
This research investigates how to enhance the prescribing of oral anticoagulants for patients diagnosed with atrial fibrillation in emergency departments. It utilizes an electronic clinical decision support tool to empower healthcare providers to make timely and appropriate treatment decisions. By focusing on the acute care setting, the study aims to address the common issue of underprescribing anticoagulants, which can significantly reduce the risk of stroke. The approach involves a stepped-wedge cluster randomized trial design to evaluate the effectiveness of this intervention in real-world emergency department settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are diagnosed with atrial fibrillation while receiving care in an emergency department.
Not a fit: Patients who do not have atrial fibrillation or those who are not treated in emergency departments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a significant reduction in stroke risk for patients with atrial fibrillation treated in emergency departments.
How similar studies have performed: Previous research has shown that clinical decision support tools can improve prescribing practices in acute care settings, indicating potential for success with this approach.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Kea, Bory — Oregon Health & Science University
- Study coordinator: Kea, Bory
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.